FDA issued a Warning Letter to OriGen Biomedical, Inc. on 12/20/2018 for a later inspection.
483 OriGen Biomedical Apr 2013

483 OriGen Biomedical Apr 2013

Daniel Fam FDA$119.00 - Available Now

FDA investigators audited the OriGen Biomedical - Austin, TX, United States facility and issued inspectional observations (via FDA 483) on 26 Apr 2013.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 26 Apr 2013
  • Location: Austin, United States
  • FEI: 1000160256
Add To Cart